Radiotherapy in Lung Cancer: Current and Future Role

Lung cancer is divided into two subgroups concerning its natural course and treatment strategies as follows: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In this review, for NSCLC, the role of stereotactic body radiation therapy (SBRT) in early-stage, chemoradiation in the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzel, Esengül Koçak, Figen, Metin, Uzel, Ömer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192301/
https://www.ncbi.nlm.nih.gov/pubmed/32377108
http://dx.doi.org/10.14744/SEMB.2019.25991
_version_ 1783527990202728448
author Uzel, Esengül Koçak
Figen, Metin
Uzel, Ömer
author_facet Uzel, Esengül Koçak
Figen, Metin
Uzel, Ömer
author_sort Uzel, Esengül Koçak
collection PubMed
description Lung cancer is divided into two subgroups concerning its natural course and treatment strategies as follows: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In this review, for NSCLC, the role of stereotactic body radiation therapy (SBRT) in early-stage, chemoradiation in the locally advanced stage, post-operative radiotherapy for patients with high risk after surgery and radiotherapy for metastatic disease will be discussed. Also, for SCLC, the role and timing of thoracic irradiation and prophylactic cranial irradiation (PCI) for the limited and extensive stages will be discussed.
format Online
Article
Text
id pubmed-7192301
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-71923012020-05-06 Radiotherapy in Lung Cancer: Current and Future Role Uzel, Esengül Koçak Figen, Metin Uzel, Ömer Sisli Etfal Hastan Tip Bul Review Lung cancer is divided into two subgroups concerning its natural course and treatment strategies as follows: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In this review, for NSCLC, the role of stereotactic body radiation therapy (SBRT) in early-stage, chemoradiation in the locally advanced stage, post-operative radiotherapy for patients with high risk after surgery and radiotherapy for metastatic disease will be discussed. Also, for SCLC, the role and timing of thoracic irradiation and prophylactic cranial irradiation (PCI) for the limited and extensive stages will be discussed. Kare Publishing 2019-11-21 /pmc/articles/PMC7192301/ /pubmed/32377108 http://dx.doi.org/10.14744/SEMB.2019.25991 Text en Copyright: © 2019 by The Medical Bulletin of Sisli Etfal Hospital http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Review
Uzel, Esengül Koçak
Figen, Metin
Uzel, Ömer
Radiotherapy in Lung Cancer: Current and Future Role
title Radiotherapy in Lung Cancer: Current and Future Role
title_full Radiotherapy in Lung Cancer: Current and Future Role
title_fullStr Radiotherapy in Lung Cancer: Current and Future Role
title_full_unstemmed Radiotherapy in Lung Cancer: Current and Future Role
title_short Radiotherapy in Lung Cancer: Current and Future Role
title_sort radiotherapy in lung cancer: current and future role
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192301/
https://www.ncbi.nlm.nih.gov/pubmed/32377108
http://dx.doi.org/10.14744/SEMB.2019.25991
work_keys_str_mv AT uzelesengulkocak radiotherapyinlungcancercurrentandfuturerole
AT figenmetin radiotherapyinlungcancercurrentandfuturerole
AT uzelomer radiotherapyinlungcancercurrentandfuturerole

Ejemplares similares